| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92b909763b9f0f22195318afdc6db240 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2001-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125cbfea762fa6cb21586c12ea3c6d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_016c7a6aa403515717ade0efed085b02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c5a5f75f58e2453ac7df5a4dadcce1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06db28234ec445f7084868f91559c250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23d658891cc4494eec1940970f81155f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28e43d522e6a57d65cc0102dc3a997ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49f20aa7fe5503ed3d17ee1e9f662f0 |
| publicationDate |
2002-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002032316-A1 |
| titleOfInvention |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| abstract |
Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013236478-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916170-B2 |
| priorityDate |
1995-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |